Daniel G Welch - Net Worth and Insider Trading
Daniel G Welch Net Worth
The estimated net worth of Daniel G Welch is at least $4 Million dollars as of 2024-11-13. Daniel G Welch is the Director of Seagen Inc and owns about 17,519 shares of Seagen Inc (SGEN) stock worth over $4 Million. Daniel G Welch is also the Director of Intercept Pharmaceuticals Inc and owns about 3,108 shares of Intercept Pharmaceuticals Inc (ICPT) stock worth over $59,052. Details can be seen in Daniel G Welch's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Daniel G Welch has not made any transactions after 2023-08-28 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Daniel G Welch
Daniel G Welch Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Daniel G Welch owns 7 companies in total, including Ultragenyx Pharmaceutical Inc (RARE) , Intercept Pharmaceuticals Inc (ICPT) , and Seagen Inc (SGEN) among others .
Click here to see the complete history of Daniel G Welch’s form 4 insider trades.
Insider Ownership Summary of Daniel G Welch
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| RARE | Ultragenyx Pharmaceutical Inc | 2015-04-08 | director |
| ICPT | Intercept Pharmaceuticals Inc | 2020-05-28 | director |
| SGEN | Seagen Inc | 2023-08-28 | director |
 | | 2018-05-15 | director |
| | 2014-04-02 | director |
| | 2021-02-10 | director |
| | 2023-02-02 | director |
Daniel G Welch Latest Holdings Summary
Daniel G Welch currently owns a total of 2 stocks. Among these stocks, Daniel G Welch owns 17,519 shares of Seagen Inc (SGEN) as of August 28, 2023, with a value of $4 Million and a weighting of 98.55%. Daniel G Welch also owns 3,108 shares of Intercept Pharmaceuticals Inc (ICPT) as of July 31, 2017, with a value of $59,052 and a weighting of 1.45%.
Latest Holdings of Daniel G Welch
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SGEN | Seagen Inc | 2023-08-28 | 17,519 | 228.74 | 4,007,296 |
| ICPT | Intercept Pharmaceuticals Inc | 2017-07-31 | 3,108 | 19.00 | 59,052 |
Holding Weightings of Daniel G Welch
Daniel G Welch Form 4 Trading Tracker
According to the SEC Form 4 filings, Daniel G Welch has made a total of 8 transactions in Seagen Inc (SGEN) over the past 5 years, including 0 buys and 8 sells. The most-recent trade in Seagen Inc is the sale of 4,925 shares on August 28, 2023, which brought Daniel G Welch around $1 Million.
According to the SEC Form 4 filings, Daniel G Welch has made a total of 0 transactions in Intercept Pharmaceuticals Inc (ICPT) over the past 5 years. The most-recent trade in Intercept Pharmaceuticals Inc is the sale of 602 shares on July 31, 2017, which brought Daniel G Welch around $74,606.
Insider Trading History of Daniel G Welch
- 1
Daniel G Welch Trading Performance
Daniel G Welch Ownership Network
Ownership Network List of Daniel G Welch
Ownership Network Relation of Daniel G Welch
Daniel G Welch Owned Company Details
What does Ultragenyx Pharmaceutical Inc do?
Who are the key executives at Ultragenyx Pharmaceutical Inc?
Daniel G Welch is the director of Ultragenyx Pharmaceutical Inc. Other key executives at Ultragenyx Pharmaceutical Inc include Chief Financial Officer Howard Horn , director & 10 percent owner & President & CEO Emil D Kakkis , and Controller and PAO Theodore Alan Huizenga .
Ultragenyx Pharmaceutical Inc (RARE) Insider Trades Summary
Over the past 18 months, Daniel G Welch made no insider transaction in Ultragenyx Pharmaceutical Inc (RARE). Other recent insider transactions involving Ultragenyx Pharmaceutical Inc (RARE) include a net sale of 147,853 shares made by Emil D Kakkis , a net sale of 4,391 shares made by Sanders Corazon (corsee) D. , and a net sale of 3,565 shares made by Theodore Alan Huizenga .
In summary, during the past 3 months, insiders sold 27,556 shares of Ultragenyx Pharmaceutical Inc (RARE) in total and bought 0 shares, with a net sale of 27,556 shares. During the past 18 months, 260,421 shares of Ultragenyx Pharmaceutical Inc (RARE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 260,421 shares.
Ultragenyx Pharmaceutical Inc (RARE)'s detailed insider trading history can be found in Insider Trading Tracker table.
Ultragenyx Pharmaceutical Inc Insider Transactions
Daniel G Welch Mailing Address
Above is the net worth, insider trading, and ownership report for Daniel G Welch. You might contact Daniel G Welch via mailing address: 4611 University Dr, 4 University Place, Durham Nc 27707.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
